by Justin Jackson , Medical Xpress Credit: Ivan Samkov from Pexels An international collaboration of researchers, sponsored by GSK and working on behalf of the ANCHOR-1 and ANCHOR-2 trial investigators, conducted two Phase III clinical trials to evaluate depemokimab, an ultra-long-acting anti-IL-5 biologic drug, for chronic rhinosinusitis with nasal polyps. Results demonstrate that depemokimab significantly...
Tag: <span>chronic rhinosinusitis</span>
Post
Nasal microorganism to the rescue? Study confirms protective role of bacterium in chronic rhinosinusitis
Scientists investigate how microbes in the nasal mucosa may influence the pathophysiology of chronic sinusitis Peer-Reviewed Publication UNIVERSITY OF FUKUI EXPERIMENTS CONDUCTED IN A RECENT STUDY BY RESEARCHERS FROM JAPAN SUGGEST THAT THE LIPOPOLYSACCHARIDES (LPS) PRODUCED BY THE BACTERIAL SPECIES F. NUCLEATUM SUPPRESSES THE EXPRESSION OF ALOX15 AND PREVENTS EXCESSIVE INFILTRATION OF EOSINOPHILS, WHICH CAUSES...